Nanostring's cosmx smi achieves whole transcriptome imaging at single-cell resolution

Seattle--(business wire)--nanostring technologies, inc. (nasdaq: nstg), a leading provider of life science tools for discovery and translational research, today announced the release of the first public dataset of the whole transcriptome obtained at true single-cell resolution on the cosmx™ spatial molecular imager (smi). the data will be highlighted at the 42nd annual j.p. morgan healthcare conference 2024 in san francisco during nanostring's corporate presentation on wednesday, january 10, 20.
NSTG Ratings Summary
NSTG Quant Ranking